Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer

World Journal of Urology

Volumn 26, Issue 5, 2008, Pages 481-485

  Misraï, Vincent ^a   Rouprêt, Morgan ^a   Chartier Kastler, Emmanuel ^a   Comperat, Eva ^a   Renard Penna, Raphaële ^a   Haertig, Alain ^a   Bitker, Marc Olivier ^a   Richard, François ^a   Conort, Pierre ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

HIFU; Localized prostate cancer; Minimally invasive therapy; Outcome; Prostate specific antigen

Indexed keywords

AGED; ARTICLE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 53549123568     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-008-0286-8     Document Type: Article

References (21)

1. Boyle P, Severi G, Giles GG (2003) The epidemiology of prostate cancer. Urol Clin North Am 30:209-217
2. Oliver SE, May MT, Gunnell D (2001) International trends in prostate-cancer mortality in the "PSA ERA". Int J Cancer 92:893-898
3. Walsh PC, DeWeese TL, Eisenberger MA (2007) Clinical practice. Localized prostate cancer. N Engl J Med 357:2696-2705
4. Chaussy C, Thuroff S (2001) Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 15:437-440 discussion 447-448
5. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F (2004) Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: Feasibility study. J Urol 171:2265-2267
6. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C et al (2007) First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol 53(6):1194-1203
7. Blana A, Walter B, Rogenhofer S, Wieland WF (2004) High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63:297-300
8. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM (2001) Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: Factors influencing the outcome. Eur Urol 40:124-129
9. Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF et al (2007) PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol 53(3):547-553
10. Poissonnier L, Chapelon JY, Rouviere O, Curiel L, Bouvier R, Martin X et al (2007) Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 51:381-387
11. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D (2002) Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol 20:4567-4573
12. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965-974
13. Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A (2006) Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 97:56-61
14. Rebillard X, Davin JL, Soulie M (2003) Treatment by HIFU of prostate cancer: Survey of literature and treatment indications. Prog Urol 13:1428-1456
15. Rebillard X, Soulie M, Chartier-Kastler E, Coulange C, Davin J, Moreau J et al (2008) High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int 101:1205-1213
16. Lee HM, Hong JH, Choi HY (2006) High-intensity focused ultrasound therapy for clinically localized prostate cancer. Prostate Cancer Prostatic Dis 9:439-443
17. Gulley JL, Figg WD, Steinberg SM, Carter J, Sartor O, Higano CS et al (2005) A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy. J Urol 173:1567-1571
18. Thuroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A et al (2003) High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17:673-677
19. Chaussy C, Thuroff S (2000) High-intensity focused ultrasound in prostate cancer: Results after 3 years. Mol Urol 4:179-182
20. Chaussy C, Thuroff S (2003) The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 4:248-252
21. Murat FJ, Poissonnier L, Pasticier G, Gelet A (2007) High-intensity focused ultrasound (HIFU) for prostate cancer. Cancer Control 14:244-249